Hay-Schmidt Anders, Finkielman Olivia T Ejlstrup, Jensen Benjamin A H, Høgsbro Christine F, Bak Holm Jacob, Johansen Kristoffer Haurum, Jensen Tina Kold, Andrade Anderson Martino, Swan Shanna H, Bornehag Carl-Gustaf, Brunak Søren, Jegou Bernard, Kristiansen Karsten, Kristensen David Møbjerg
Department of Neuroscience and PharmacologyFaculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark.
Department of BiologyFaculty of Science, University of Copenhagen, Copenhagen, Denmark.
Reproduction. 2017 Aug;154(2):145-152. doi: 10.1530/REP-17-0165. Epub 2017 May 30.
Paracetamol/acetaminophen (N-Acetyl-p-Aminophenol; APAP) is the preferred analgesic for pain relief and fever during pregnancy. It has therefore caused concern that several studies have reported that prenatal exposure to APAP results in developmental alterations in both the reproductive tract and the brain. Genitals and nervous system of male mammals are actively masculinised during foetal development and early postnatal life by the combined actions of prostaglandins and androgens, resulting in the male-typical reproductive behaviour seen in adulthood. Both androgens and prostaglandins are known to be inhibited by APAP. Through intrauterine exposure experiments in C57BL/6 mice, we found that exposure to APAP decreased neuronal number in the sexually dimorphic nucleus (SDN) of the preoptic area (POA) in the anterior hypothalamus of male adult offspring. Likewise, exposure to the environmental pollutant and precursor of APAP, aniline, resulted in a similar reduction. Decrease in neuronal number in the SDN-POA is associated with reductions in male sexual behaviour. Consistent with the changes, male mice exposed to APAP exhibited changes in urinary marking behaviour as adults and had a less aggressive territorial display towards intruders of the same gender. Additionally, exposed males had reduced intromissions and ejaculations during mating with females in oestrus. Together, these data suggest that prenatal exposure to APAP may impair male sexual behaviour in adulthood by disrupting the sexual neurobehavioral programming. These findings add to the growing body of evidence suggesting the need to limit the widespread exposure and use of APAP by pregnant women.
对乙酰氨基酚(N - 乙酰 - 对氨基苯酚;APAP)是孕期缓解疼痛和退烧的首选镇痛药。因此,有几项研究报告称,产前接触APAP会导致生殖道和大脑发育改变,这引起了人们的关注。在胎儿发育和出生后早期,雄性哺乳动物的生殖器和神经系统会通过前列腺素和雄激素的共同作用而积极地雄性化,从而导致成年后出现典型的雄性生殖行为。已知雄激素和前列腺素都会被APAP抑制。通过对C57BL/6小鼠进行宫内暴露实验,我们发现,成年雄性后代前下丘脑视前区(POA)的性二态核(SDN)中,接触APAP会减少神经元数量。同样,接触环境污染物及APAP的前体苯胺也会导致类似的减少。SDN - POA中神经元数量的减少与雄性性行为的减少有关。与这些变化一致,成年后接触APAP的雄性小鼠在尿液标记行为上出现了变化,并且对同性入侵者的领地攻击性展示减少。此外,接触过APAP的雄性在与处于发情期的雌性交配时,插入和射精次数减少。总之,这些数据表明,产前接触APAP可能会通过破坏性神经行为编程而损害成年雄性的性行为。这些发现进一步增加了越来越多的证据,表明有必要限制孕妇广泛接触和使用APAP。